By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug for you depends on more.

More patients on Eli Lilly’s tirzepatide lost over 5% of their lean mass versus those on Novo Nordisk’s semaglutide, ...

The SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or ...

The rivalry between Lilly's tirzepatide and Novo's semaglutide continues as new study finds that tirzepatide leads to greater ...

Fact checked by Nick Blackmer Tirzepatide might cause more side effects than semaglutide due to dual hormone action.Some ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Eli Lilly's tirzepatide, more effective at weight loss than Novo Nordisk's semaglutide, also causes greater lean body mass loss according to a new study. The study compared 1,800 tirzepatide users ...

No significant increase in hazard ratios seen for GI events for semaglutide vs dulaglutide, tirzepatide vs dulaglutide, tirzepatide vs semaglutide. HealthDay News For patients with type 2 diabetes ...